EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-25%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$2.39B
AUM Growth
–
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
77.94%
Holding
271
New
271
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Alibaba
BABA
|
$947M |
| 2 |
JD.com
JD
|
$216M |
| 3 |
Pinduoduo
PDD
|
$195M |
| 4 |
Baidu
BIDU
|
$171M |
| 5 |
NetEase
NTES
|
$111M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Discretionary | 62.14% |
| 2 | Communication Services | 18.47% |
| 3 | Technology | 9.22% |
| 4 | Healthcare | 3.01% |
| 5 | Financials | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Broadridge
BR
$29.4B
| $209K | 0.01% |
+1,252
| New | +$209K |
|
227
Cytokinetics
CYTK
$6.34B
| $209K | 0.01% |
+5,840
| New | +$209K |
|
228
Deere & Co
DE
$128B
| $208K | 0.01% |
+620
| New | +$208K |
|
229
Arista Networks
ANET
$180B
| $203K | 0.01% |
+9,472
| New | +$203K |
|
230
Qorvo
QRVO
$8.61B
| $203K | 0.01% |
+1,214
| New | +$203K |
|
231
Hewlett Packard
HPE
$31B
| $202K | 0.01% |
+14,077
| New | +$202K |
|
232
Prologis
PLD
$105B
| $201K | 0.01% |
+1,599
| New | +$201K |
|
233
Zimmer Biomet
ZBH
$20.9B
| $201K | 0.01% |
+1,410
| New | +$201K |
|
234
Seres Therapeutics
MCRB
$169M
| $191K | 0.01% |
+1,375
| New | +$191K |
|
|
CCXI
235
DELISTED
ChemoCentryx, Inc.
CCXI
| $191K | 0.01% |
+11,179
| New | +$191K |
|
236
Ironwood Pharmaceuticals
IRWD
$188M
| $185K | 0.01% |
+14,130
| New | +$185K |
|
237
Acadia Pharmaceuticals
ACAD
$4.26B
| $177K | 0.01% |
+10,673
| New | +$177K |
|
|
CLVS
238
DELISTED
Clovis Oncology, Inc.
CLVS
| $176K | 0.01% |
+39,535
| New | +$176K |
|
239
Ocugen
OCGN
$322M
| $173K | 0.01% |
+24,109
| New | +$173K |
|
240
Opko Health
OPK
$1.07B
| $170K | 0.01% |
+46,542
| New | +$170K |
|
|
SRNE
241
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $166K | 0.01% |
+21,764
| New | +$166K |
|
242
BioCryst Pharmaceuticals
BCRX
$1.74B
| $163K | 0.01% |
+11,349
| New | +$163K |
|
243
Viatris
VTRS
$12.2B
| $161K | 0.01% |
+11,881
| New | +$161K |
|
244
Heron Therapeutics
HRTX
$201M
| $158K | 0.01% |
+14,805
| New | +$158K |
|
|
VXRT
245
DELISTED
Vaxart
VXRT
| $157K | 0.01% |
+19,803
| New | +$157K |
|
246
Curis
CRIS
$21M
| $156K | 0.01% |
+994
| New | +$156K |
|
|
GTHX
247
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $156K | 0.01% |
+11,607
| New | +$156K |
|
248
FibroGen
FGEN
$48.9M
| $155K | 0.01% |
+608
| New | +$155K |
|
249
Inovio Pharmaceuticals
INO
$148M
| $155K | 0.01% |
+1,807
| New | +$155K |
|
250
Amicus Therapeutics
FOLD
$2.46B
| $151K | 0.01% |
+15,771
| New | +$151K |
|